BioBlast Pharma withdraws follow-on

Rare disease play BioBlast Pharma Ltd. (NASDAQ:ORPN) withdrew its follow-on underwritten by H.C. Wainwright on April 6, citing market conditions. In February, the company proposed to raise up to $11....